From Understanding to Healing: Exploring the Role of Psychopharmacology in Self-Harm Behaviors & Suicide Risk Prevention for Adolescence & Young Adults
-
Register
- User - $35
It is important for NP's to recognize and address how childhood & adolescent adversity and stressful life events can inform and empower clinical practice for supporting patients in any setting. This presentation aims help improve knowledge and strengthen the therapeutic alliance for NP's & patients for prevention & treatments to mitigate the emergence of psychopathology in adult life-stages
Credits: 1.50 Contact Hours; 0.75 are Pharmacology
Expiration Date: December 31st, 2025
$35
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Improve knowledge of terminology, risk factors, and developmental process of psychopathologies that impact the emergence NSSI in adolescent & young adults.
-Identify standardized methods for the assessment, evaluation and evidence for NSSI interventions to improve patient outcomes.
-Apply evidence-based practice to utilize a safe, effective, & appropriate pharmacologic treatment for NSSI & common psychiatric disorders
Ryan Kennedy, DNP, NP-C
Doctor
Associate Director of the Brown Clinic for Attention & Related Disorders
Dr. Ryan J. Kennedy is Associate Director of the Brown Clinic for Attention & Related Disorders and specializes in assessment and treatment of ADHD for children and adults. Dr. Kennedy received his Doctorate in Nursing Practice from Quinnipiac University. In 2011, he began his career as Research Assistant to Yale Professor, Dr. Thomas E. Brown, at the Yale Clinic for Attention & Related Disorders. In 2017, Dr. Kennedy relocated with Dr. Brown to open their private practice in Manhattan Beach, CA. Dr. Kennedy regularly participates in scientific research, speaker, & expert in psychopharmacology for ADHD. He has presented in twelve countries at national and international conferences and universities for lectures and workshops to educate professionals on the latest developments in ADHD and Related Disorders. He is published in peer-reviewed journals, books and is a coauthor of the first open-access eBook published by the World Federation of ADHD.
Dr. Kennedy also provides ongoing mentoring for Pediatric Resident-Physicians enrolled at the University of California-Los Angeles.
CE INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Dashboard' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 0.75 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Accreditation Statement
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
DISCLOSURES
Faculty
Contributing faculty, Ryan Kennedy, DNP, FNP-C has disclosed:
Supernus
Honoraria / Advisory Board ADHD Treatment
Qelbree (non-stimulant)
Tris Pharma Honoraria / Consultatant ADHD Treatment Dyanavel-XR
CA Associ. NP Honoraria / C.E. Speaker Fee Mental Health
FDA approved ADHD Medications
American Psychiatric Press Honoraria / Conference Speaker ADHD & Autism FDA approved ADHD/Autism Drugs
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
